We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

145 hedge funds and large institutions have $1.11B invested in Alder Biopharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 65 increasing their positions, 38 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $2.78M | Put options by funds: $642K

71% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 38

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

9% less funds holding

Funds holding: 159 → 145 (-14)

36% less capital invested

Capital invested by funds: $1.73B → $1.11B (-$620M)

43% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 30

Holders
145
Holders Change
-14
Holders Change %
-8.81%
% of All Funds
3.63%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
17
Increased
65
Reduced
38
Closed
30
Calls
$2.78M
Puts
$642K
Net Calls
+$2.14M
Net Calls Change
+$10.3M

Top Buyers

1
PHS
PFM Health Sciences
California
+$23.6M
2
JHIU
Janus Henderson Investors US
Colorado
+$9.57M
3
CCP
Clough Capital Partners
Massachusetts
+$7.65M
4
BFA
BlackRock Fund Advisors
California
+$7.24M
5
State Street
State Street
Massachusetts
+$6.97M

Top Sellers

1
SIG
Senator Investment Group
New York
-$32.8M
2
Citadel Advisors
Citadel Advisors
Florida
-$20.8M
3
Marshall Wace
Marshall Wace
United Kingdom
-$12.2M
4
Asset Management One
Asset Management One
Japan
-$9.69M
5
DCM
Driehaus Capital Management
Illinois
-$7.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
101
State Board of Administration of Florida Retirement System
Florida
$457K +$4.16K +160 +0.7%
SG Americas Securities
102
SG Americas Securities
New York
$453K +$481K +18,516 +570%
ACH
103
ArrowMark Colorado Holdings
Colorado
$437K +$12.2K +468 +2%
VOYA Investment Management
104
VOYA Investment Management
Georgia
$428K – – –
TD Asset Management
105
TD Asset Management
Ontario, Canada
$420K +$215K +8,269 +69%
BlackRock
106
BlackRock
New York
$385K +$105K +4,045 +28%
FRM
107
Fox Run Management
Connecticut
$364K +$455K +17,500 New
RJA
108
Raymond James & Associates
Florida
$356K +$650 +25 +0.1%
Baird Financial Group
109
Baird Financial Group
Wisconsin
$356K +$47.9K +1,841 +12%
Russell Investments Group
110
Russell Investments Group
United Kingdom
$334K +$420K +16,142 New
Legal & General Group
111
Legal & General Group
United Kingdom
$318K +$135K +5,202 +52%
BC
112
Birchview Capital
Vermont
$315K – – –
CG
113
Cutler Group
California
$267K +$203K +7,811 +154%
Barclays
114
Barclays
United Kingdom
$262K +$254K +9,755 +348%
Susquehanna International Group
115
Susquehanna International Group
Pennsylvania
$252K +$315K +12,124 New
DSI
116
Daiwa SB Investments
Japan
$250K -$103K -3,960 -25%
UBS AM
117
UBS AM
Illinois
$231K -$238K -9,142 -45%
SGAM
118
Smith Group Asset Management
Texas
$224K – – –
HSBC Holdings
119
HSBC Holdings
United Kingdom
$218K +$273K +10,480 New
Canada Life
120
Canada Life
Manitoba, Canada
$109K – – –
JAM
121
JW Asset Management
Florida
$104K – – –
PNC Financial Services Group
122
PNC Financial Services Group
Pennsylvania
$88K – – –
TRCT
123
Tower Research Capital (TRC)
New York
$88K +$110K +4,218 +46,867%
CSS
124
Cubist Systematic Strategies
Connecticut
$83K +$68.5K +2,633 +191%
BJ
125
BlackRock Japan
Japan
$33K +$32.1K +1,233 +362%
3 4
5
6 7

ALDR Hedge Fund Activity: Q4 2016 in Review

145 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q4 2016, worth a combined $1.11B — down 36% from $1.73B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of ALDR and 17 opened new positions — a net loss of 13 holders — while 38 trimmed existing stakes and 65 added.

The largest buyer was PFM Health Sciences, adding an estimated $23.6M. The largest seller was Senator Investment Group, exiting entirely with an estimated $32.8M sold.

  • 145 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q4 2016, down from 159 in Q3 2016.
  • Funds reported $1.11B of Alder Biopharmaceuticals stock for Q4 2016, down 36% quarter-over-quarter.
  • 17 funds opened new Alder Biopharmaceuticals positions in Q4 2016 and 30 closed out, a net change of -13 holders.
  • The largest Alder Biopharmaceuticals buyer in Q4 2016 was PFM Health Sciences, an estimated $23.6M added.
  • The largest Alder Biopharmaceuticals seller in Q4 2016 was Senator Investment Group, an estimated $32.8M sold.

Based on aggregated 13F filings for Q4 2016.